Preferred Label : DHAC/Rituximab Regimen;
NCIt synonyms : Carboplatin/Cytarabine/Dexamethasone/Rituximab; Dexamethasone/High-dose Cytarabine/Carboplatin/Rituximab; Dexamethasone/High-dose Ara-C/Carboplatin/Rituximab; DHAC Plus Rituximab; Dexamethasone/Cytarabine/Carboplatin/Rituximab; Dexamethasone-Cytarabine-Carboplatin-Rituximab; Carboplatin-Cytarabine-Dexamethasone -Rituximab; DHAC-R;
NCIt related terms : R-DHAC (rituximab-abbs); R-DHAC (rituximab-arrx); R-DHAC (rituximab-blit); R-DHAC (rituximab-rixa); R-DHAC (rituximab-rite); R-DHAC (rituximab-rixi); R-DHAC; R-DHAC (rituximab-pvvr);
NCIt definition : A regimen consisting of carboplatin, cytarabine, dexamethasone and rituximab that
can be used for the treatment of diffuse large B-cell lymphoma and mantle cell lymphoma.;
NCI Metathesaurus CUI : CL1912834;
Codes from synonyms : 128617; 128774; 127989; 24453; 128303; 127832; 128460; 128146;
Origin ID : C192836;
UMLS CUI : C5785455;
Semantic type(s)
- chemotherapy_regimen_has_component
- concept_is_in_subset
